Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | delta tubulin, putative | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | zeta tubulin, putative | Curated by TDR Targets | References |
Leishmania major | gamma-tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | epsilon tubulin, putative | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Trypanosoma brucei | epsilon tubulin | epsilon tubulin, putative | 470 aa | 488 aa | 68.0 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin epsilon chain, putative | gamma-tubulin | 447 aa | 479 aa | 28.2 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0161 | 0.0411 | 0.0832 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0096 | 0.0225 | 0.0225 |
Onchocerca volvulus | Putative neutral sphingomyelinase | 0.0048 | 0.0087 | 0.0209 |
Leishmania major | DNA polymerase eta, putative | 0.0165 | 0.0423 | 0.0421 |
Schistosoma mansoni | alpha tubulin | 0.0471 | 0.1297 | 0.1296 |
Giardia lamblia | Alpha-tubulin | 0.0471 | 0.1297 | 0.7463 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Leishmania major | DNA polymerase kappa, putative | 0.0043 | 0.0072 | 0.007 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0033 | 0.0045 | 0.0045 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0088 | 0.0202 | 0.0426 |
Loa Loa (eye worm) | RecQ helicase | 0.0023 | 0.0015 | 0.0015 |
Plasmodium vivax | hypothetical protein, conserved | 0.0023 | 0.0015 | 0.0072 |
Schistosoma mansoni | chromobox protein | 0.0023 | 0.0015 | 0.0013 |
Loa Loa (eye worm) | tubulin gamma chain | 0.0384 | 0.1049 | 0.1049 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0019 | 0.0003 | 0.0001 |
Echinococcus multilocularis | flap endonuclease GEN 1 | 0.0039 | 0.0062 | 0.0062 |
Leishmania major | DNA damage repair protein, putative | 0.0043 | 0.0072 | 0.007 |
Plasmodium falciparum | carbonic anhydrase | 0.1339 | 0.3781 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0084 | 0.019 | 0.0187 |
Brugia malayi | Tubulin gamma chain | 0.0384 | 0.1049 | 0.1047 |
Plasmodium vivax | hypothetical protein, conserved | 0.0048 | 0.0087 | 0.0486 |
Brugia malayi | Muscleblind-like protein | 0.0324 | 0.0876 | 0.0874 |
Echinococcus multilocularis | chromodomain helicase DNA binding protein 1 | 0.0023 | 0.0015 | 0.0015 |
Leishmania major | delta tubulin, putative | 0.0363 | 0.0987 | 0.0985 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0085 | 0.0194 | 0.1102 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0108 | 0.0215 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0237 | 0.0628 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.003 | 0.0034 | 0.0032 |
Trypanosoma cruzi | DNA repair protein RAD2, putative | 0.0039 | 0.0062 | 0.0059 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0091 | 0.0211 | 0.0211 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.0139 | 0.0215 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.003 | 0.0034 | 0.0032 |
Onchocerca volvulus | 0.0234 | 0.0619 | 0.1755 | |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.002 | 0.0007 | 0.0013 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.003 | 0.0034 | 0.0032 |
Schistosoma mansoni | tubulin subunit beta | 0.0161 | 0.0411 | 0.0409 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0087 | 0.0087 |
Echinococcus granulosus | smad | 0.0033 | 0.0045 | 0.0045 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0056 | 0.0109 | 0.0107 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Echinococcus granulosus | synaptojanin 1 | 0.0048 | 0.0087 | 0.0087 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0045 | 0.0078 | 0.0076 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Toxoplasma gondii | beta-1 tubulin, putative | 0.0625 | 0.1737 | 0.4591 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.0139 | 0.0137 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0059 | 0.0119 | 0.0238 |
Brugia malayi | CXXC zinc finger family protein | 0.0031 | 0.0038 | 0.0036 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.0003 | 0.0001 |
Plasmodium vivax | tubulin alpha chain, putative | 0.0471 | 0.1297 | 0.7463 |
Schistosoma mansoni | carbonic anhydrase | 0.1657 | 0.4691 | 0.469 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.0086 | 0.017 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0108 |
Toxoplasma gondii | hypothetical protein | 0.0052 | 0.01 | 0.0258 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0.0026 | 0.0047 |
Loa Loa (eye worm) | tubulin beta-2A chain | 0.0625 | 0.1737 | 0.1737 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0057 | 0.0114 | 0.0227 |
Schistosoma mansoni | hypothetical protein | 0.0916 | 0.257 | 0.2569 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Echinococcus multilocularis | tubulin alpha | 0.0351 | 0.0955 | 0.0955 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.003 | 0.0034 | 0.0034 |
Echinococcus multilocularis | geminin | 0.0916 | 0.257 | 0.257 |
Echinococcus multilocularis | protein dispatched 1 | 0.0104 | 0.0247 | 0.0247 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 0.0369 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0031 | 0.0038 | 0.0038 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0053 | 0.0101 | 0.02 |
Echinococcus multilocularis | tubulin alpha 1C chain | 0.0471 | 0.1297 | 0.1297 |
Plasmodium vivax | tubulin beta chain, putative | 0.0625 | 0.1737 | 1 |
Brugia malayi | Tubulin alpha chain | 0.0471 | 0.1297 | 0.1295 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0154 | 0.039 | 0.0388 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0292 | 0.0292 |
Schistosoma mansoni | hypothetical protein | 0.0088 | 0.0201 | 0.02 |
Brugia malayi | Ets-domain containing protein | 0.0078 | 0.0173 | 0.0171 |
Entamoeba histolytica | inositol polyphosphate 5-phosphatase, putative | 0.0048 | 0.0087 | 0.018 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0502 | 0.1386 | 0.1386 |
Loa Loa (eye worm) | tubulin alpha-2 chain | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0066 | 0.0138 | 0.0275 |
Trichomonas vaginalis | tubulin, putative | 0.0194 | 0.0504 | 0.1022 |
Echinococcus multilocularis | importin subunit beta 1 | 0.0025 | 0.0021 | 0.0021 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.012 | 0.0292 | 0.029 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.004 | 0.0064 | 0.0064 |
Entamoeba histolytica | exonuclease, putative | 0.0039 | 0.0062 | 0.0126 |
Wolbachia endosymbiont of Brugia malayi | 2,3,4,5-tetrahydropyridine-2,6-carboxylate N-succinyltransferase | 0.008 | 0.018 | 0.2453 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Loa Loa (eye worm) | BEN-1 protein | 0.0625 | 0.1737 | 0.1737 |
Brugia malayi | Tubulin beta chain | 0.0161 | 0.0411 | 0.0408 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0084 | 0.019 | 0.051 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase | 0.0134 | 0.0332 | 0.033 |
Toxoplasma gondii | alpha-tubulin I, putative | 0.0471 | 0.1297 | 0.3426 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0046 | 0.008 | 0.0166 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.019 | 0.0494 | 0.1002 |
Trichomonas vaginalis | esterase, putative | 0.012 | 0.0292 | 0.059 |
Mycobacterium ulcerans | transmembrane carbonic anhydrase, SulP | 0.0037 | 0.0056 | 0.0045 |
Brugia malayi | beta-lactamase family protein | 0.012 | 0.0292 | 0.029 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0.0082 | 0.0079 |
Echinococcus granulosus | geminin | 0.0916 | 0.257 | 0.257 |
Echinococcus granulosus | chromodomain helicase DNA binding protein 4 | 0.0025 | 0.002 | 0.002 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Echinococcus multilocularis | muscleblind protein | 0.0324 | 0.0876 | 0.0876 |
Toxoplasma gondii | hypothetical protein | 0.0051 | 0.0094 | 0.0243 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0072 | 0.007 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0025 | 0.0021 | 0.005 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0066 | 0.0138 | 0.0275 |
Mycobacterium leprae | PROBABLE TRANSFERASE | 0.0077 | 0.0171 | 0.0257 |
Echinococcus multilocularis | Jumonji, AT rich interactive domain 1B | 0.0019 | 0.0003 | 0.0003 |
Echinococcus granulosus | dna polymerase eta | 0.0165 | 0.0423 | 0.0423 |
Schistosoma mansoni | carbonic anhydrase-related | 0.1339 | 0.3781 | 0.378 |
Echinococcus multilocularis | deoxyribonuclease 1 2 | 0.0048 | 0.0087 | 0.0087 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0237 | 0.0628 | 0.0626 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0046 | 0.0081 | 0.0078 |
Loa Loa (eye worm) | hypothetical protein | 0.0103 | 0.0244 | 0.0244 |
Echinococcus granulosus | tubulin subunit TubB | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0023 | 0.0015 | 0.0026 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Plasmodium vivax | glutathione reductase, putative | 0.0085 | 0.0194 | 0.1102 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.0269 | 0.0269 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.1339 | 0.3781 | 0.3779 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0237 | 0.0628 | 0.0628 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0243 | 0.0644 | 0.0641 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0048 | 0.0087 | 0.0084 |
Echinococcus multilocularis | tubulin alpha 3 chain | 0.0471 | 0.1297 | 0.1297 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.012 | 0.0292 | 0.029 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Echinococcus granulosus | flap endonuclease GEN 1 | 0.0039 | 0.0062 | 0.0062 |
Trypanosoma cruzi | beta tubulin, putative | 0.0625 | 0.1737 | 0.1735 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.0139 | 0.0215 |
Echinococcus multilocularis | beta tubulin | 0.0625 | 0.1737 | 0.1737 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0194 | 0.0506 | 0.1522 |
Echinococcus granulosus | Tubulin alpha 1 chain | 0.0471 | 0.1297 | 0.1297 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.034 | 0.0924 | 0.0924 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.0471 | 0.1297 | 0.2637 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0278 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Loa Loa (eye worm) | Smad1 | 0.0033 | 0.0045 | 0.0045 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1339 | 0.3781 | 0.3779 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0746 | 0.2085 | 0.2083 |
Toxoplasma gondii | tubulin, putative | 0.0032 | 0.0042 | 0.0104 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.0211 | 0.0211 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0108 |
Chlamydia trachomatis | sulfate transporter | 0.0037 | 0.0056 | 0.0656 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0022 | 0.0012 | 0.0009 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1737 | 0.1736 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0736 | 0.2055 | 0.2053 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0042 | 0.0069 | 0.0385 |
Trypanosoma brucei | DNA-(apurinic or apyrimidinic site) lyase, putative | 0.0048 | 0.0087 | 0.0084 |
Echinococcus multilocularis | smad | 0.0033 | 0.0045 | 0.0045 |
Plasmodium falciparum | alpha tubulin 1 | 0.0471 | 0.1297 | 0.3426 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Schistosoma mansoni | carbonic anhydrase-related | 0.1339 | 0.3781 | 0.378 |
Trypanosoma brucei | unspecified product | 0.0095 | 0.0222 | 0.022 |
Trypanosoma cruzi | endonuclease/exonuclease/phosphatase, putative | 0.0048 | 0.0087 | 0.0084 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0138 | 0.0344 | 0.0344 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.1339 | 0.3781 | 0.3779 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.003 | 0.0034 | 0.0034 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0138 | 0.0344 | 0.1 |
Loa Loa (eye worm) | hypothetical protein | 0.1339 | 0.3781 | 0.3781 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0085 | 0.0194 | 0.0191 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0065 | 0.0136 | 0.0134 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0092 | 0.0091 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0193 | 0.0501 | 0.2872 |
Schistosoma mansoni | flap endonuclease-1 | 0.0174 | 0.0448 | 0.0446 |
Leishmania major | hypothetical protein, conserved | 0.0048 | 0.0087 | 0.0084 |
Loa Loa (eye worm) | tubulin alpha 2 | 0.031 | 0.0836 | 0.0836 |
Schistosoma mansoni | hypothetical protein | 0.0088 | 0.0201 | 0.02 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1737 | 0.1736 |
Plasmodium vivax | hypothetical protein, conserved | 0.012 | 0.0292 | 0.1669 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Mycobacterium tuberculosis | Probable serine acetyltransferase CysE (sat) | 0.008 | 0.018 | 0.047 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0055 | 0.0108 | 0.0105 |
Schistosoma mansoni | ran | 0.0018 | 0.0002 | 0.0001 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.012 | 0.0292 | 0.0831 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.0392 | 0.0392 |
Treponema pallidum | hypothetical protein | 0.0048 | 0.0087 | 0.0883 |
Plasmodium vivax | tubulin gamma chain, putative | 0.0384 | 0.1049 | 0.6031 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.1657 | 0.4691 | 1 |
Mycobacterium leprae | Probable transmembrane transport protein | 0.027 | 0.0722 | 0.1445 |
Leishmania major | hypothetical protein, conserved | 0.0042 | 0.0069 | 0.0067 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.012 | 0.0292 | 0.0529 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0039 | 0.0062 | 0.0157 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0325 | 0.0881 | 0.0878 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1297 | 0.2637 |
Giardia lamblia | DINP protein human, muc B family | 0.0172 | 0.0443 | 0.2541 |
Echinococcus granulosus | cpg binding protein | 0.0033 | 0.0043 | 0.0043 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0138 | 0.0344 | 0.0729 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0065 | 0.0136 | 0.0136 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.003 | 0.0034 | 0.0032 |
Echinococcus multilocularis | chromobox protein 2 | 0.0023 | 0.0015 | 0.0015 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0277 | 0.0742 | 0.1507 |
Brugia malayi | hypothetical protein | 0.0023 | 0.0015 | 0.0013 |
Echinococcus granulosus | tumor protein p63 | 0.0703 | 0.1962 | 0.1962 |
Loa Loa (eye worm) | tubulin alpha 2 | 0.031 | 0.0836 | 0.0836 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0088 | 0.0202 | 0.0202 |
Brugia malayi | hypothetical protein | 0.0132 | 0.0327 | 0.0325 |
Mycobacterium tuberculosis | Conserved protein | 0.012 | 0.0292 | 0.0831 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Giardia lamblia | Beta tubulin | 0.0625 | 0.1737 | 1 |
Echinococcus granulosus | dnaJ subfamily B | 0.0441 | 0.121 | 0.121 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.007 | 0.0151 | 0.0302 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.003 | 0.0034 | 0.0084 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.3512 | 1 | 1 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Trichomonas vaginalis | maltose O-acetyltransferase, putative | 0.0077 | 0.0171 | 0.0344 |
Toxoplasma gondii | hypothetical protein | 0.1339 | 0.3781 | 1 |
Mycobacterium leprae | ATP-dependent Clp protease proteolytic subunit 1 | 0.0051 | 0.0094 | 0.0091 |
Mycobacterium tuberculosis | Probable reductase | 0.0194 | 0.0506 | 0.1522 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.0072 | 0.0078 |
Leishmania major | hypothetical protein, conserved | 0.0048 | 0.0087 | 0.0084 |
Loa Loa (eye worm) | GTP-binding nuclear protein RAN/TC4 | 0.0018 | 0.0002 | 0.0002 |
Echinococcus multilocularis | GTP binding nuclear protein Ran | 0.0018 | 0.0002 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.008 | 0.008 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0055 | 0.0108 | 0.0278 |
Echinococcus multilocularis | snurportin 1 | 0.0268 | 0.0715 | 0.0715 |
Brugia malayi | CHE-14 protein | 0.0091 | 0.0211 | 0.0208 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0037 | 0.0055 | 0.0052 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0066 | 0.0139 | 0.0139 |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, putative | 0.0134 | 0.0332 | 0.0703 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0053 | 0.0101 | 0.02 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0108 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1737 | 0.1736 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0237 | 0.0628 | 0.1218 |
Echinococcus granulosus | Chromo domain | 0.0023 | 0.0015 | 0.0015 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0088 | 0.0202 | 0.0202 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0087 | 0.0087 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Mycobacterium leprae | conserved hypothetical protein | 0.012 | 0.0292 | 0.0517 |
Echinococcus multilocularis | tubulin gamma 1 chain | 0.0384 | 0.1049 | 0.1049 |
Loa Loa (eye worm) | RNA binding protein | 0.0054 | 0.0105 | 0.0105 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.0038 | 0.0037 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0088 | 0.0202 | 0.02 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.003 | 0.0034 | 0.0034 |
Trypanosoma cruzi | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | glutathione reductase | 0.0085 | 0.0194 | 0.0191 |
Trypanosoma brucei | tubulin gamma chain | 0.0384 | 0.1049 | 0.1046 |
Brugia malayi | jmjC domain containing protein | 0.0065 | 0.0136 | 0.0134 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0001 | 0.0001 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0161 | 0.0411 | 0.0832 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Leishmania major | endonuclease/exonuclease protein-like protein | 0.0048 | 0.0087 | 0.0084 |
Echinococcus multilocularis | tubulin, beta 4A class IVa | 0.0625 | 0.1737 | 0.1737 |
Entamoeba histolytica | DNA-repair protein, putative | 0.0039 | 0.0062 | 0.0126 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0048 | 0.0087 | 0.0087 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.0034 | 0.0065 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.0185 | 0.0185 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.004 | 0.0065 | 0.0065 |
Echinococcus multilocularis | GPCR, family 2 | 0.034 | 0.0924 | 0.0924 |
Loa Loa (eye worm) | nuclear factor I | 0.0018 | 0.0002 | 0.0002 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.019 | 0.0494 | 0.1002 |
Echinococcus granulosus | expressed protein | 0.0137 | 0.0341 | 0.0341 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.012 | 0.0292 | 0.059 |
Trichomonas vaginalis | type II inositol 5-phosphatase, putative | 0.0048 | 0.0087 | 0.0172 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Echinococcus multilocularis | chromodomain helicase DNA binding protein 4 | 0.0025 | 0.002 | 0.002 |
Trichomonas vaginalis | tubulin, putative | 0.019 | 0.0494 | 0.1002 |
Brugia malayi | CCR4 | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | Associated with TFs and helicases family protein | 0.0023 | 0.0015 | 0.0013 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.019 | 0.0494 | 0.1002 |
Schistosoma mansoni | carbon catabolite repressor protein | 0.0048 | 0.0087 | 0.0085 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0035 | 0.0049 | 0.0049 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0092 | 0.0092 |
Leishmania major | hypothetical protein, conserved | 0.012 | 0.0292 | 0.029 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Echinococcus granulosus | carbonic anhydrase | 0.1339 | 0.3781 | 0.3781 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | TAR-binding protein | 0.0054 | 0.0105 | 0.0102 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0033 | 0.0045 | 0.0043 |
Schistosoma mansoni | hypothetical protein | 0.0088 | 0.0201 | 0.02 |
Brugia malayi | Pre-SET motif family protein | 0.0035 | 0.0049 | 0.0047 |
Echinococcus multilocularis | Chromo domain | 0.0023 | 0.0015 | 0.0015 |
Loa Loa (eye worm) | CCR4-NOT transcription complex subunit 6 family protein | 0.0048 | 0.0087 | 0.0087 |
Brugia malayi | M-phase phosphoprotein, mpp8 | 0.0023 | 0.0015 | 0.0013 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0078 | 0.0173 | 0.0348 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0055 | 0.0108 | 0.0105 |
Brugia malayi | Tubulin alpha-2 chain | 0.0471 | 0.1297 | 0.1295 |
Trypanosoma cruzi | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0033 | 0.0045 | 0.0045 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.012 | 0.0292 | 0.029 |
Onchocerca volvulus | 0.1225 | 0.3454 | 1 | |
Brugia malayi | alpha-tubulin | 0.0471 | 0.1297 | 0.1295 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.012 | 0.0292 | 0.059 |
Schistosoma mansoni | alpha tubulin | 0.0471 | 0.1297 | 0.1296 |
Schistosoma mansoni | intermediate filament proteins | 0.0084 | 0.019 | 0.0188 |
Onchocerca volvulus | 0.0023 | 0.0015 | 0.000000011907 | |
Onchocerca volvulus | 0.0048 | 0.0087 | 0.0209 | |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.003 | 0.0034 | 0.0032 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0067 | 0.0141 | 0.0139 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0078 | 0.0173 | 0.0173 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.019 | 0.0494 | 0.1002 |
Mycobacterium ulcerans | putative regulatory protein | 0.0048 | 0.0088 | 0.0111 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0023 | 0.0015 | 0.0013 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0063 | 0.0131 | 0.0131 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0471 | 0.1297 | 0.2637 |
Leishmania major | hypothetical protein, conserved | 0.0039 | 0.0062 | 0.0059 |
Plasmodium falciparum | endonuclease, putative | 0.0021 | 0.0009 | 0.0017 |
Echinococcus granulosus | Smad4 | 0.0033 | 0.0045 | 0.0045 |
Loa Loa (eye worm) | alpha-tubulin isotype 2 | 0.031 | 0.0836 | 0.0836 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0015 | 0.0015 |
Entamoeba histolytica | tubulin alpha-1 chain | 0.0471 | 0.1297 | 0.2761 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0625 | 0.1737 | 0.3534 |
Mycobacterium ulcerans | hypothetical protein | 0.0046 | 0.0082 | 0.0098 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0027 | 0.0025 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.013 | 0.0321 | 0.0318 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0237 | 0.0628 | 0.1335 |
Echinococcus granulosus | bloom syndrome protein | 0.0023 | 0.0015 | 0.0015 |
Onchocerca volvulus | 0.0084 | 0.019 | 0.0508 | |
Trypanosoma cruzi | Sulfate transporter N-terminal domain with GLY motif/Sulfate transporter family, putative | 0.0037 | 0.0056 | 0.0054 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0096 | 0.0225 | 0.0615 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.0034 | 0.0065 |
Echinococcus granulosus | neuropeptide s receptor | 0.0502 | 0.1386 | 0.1386 |
Entamoeba histolytica | tubulin family protein | 0.0625 | 0.1737 | 0.37 |
Echinococcus granulosus | snurportin 1 | 0.0268 | 0.0715 | 0.0715 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0087 | 0.0085 |
Onchocerca volvulus | 0.0103 | 0.0244 | 0.0667 | |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0125 | 0.0125 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Toxoplasma gondii | exonuclease III APE | 0.0237 | 0.0628 | 0.1657 |
Plasmodium vivax | endonuclease/exonuclease/phosphatase domain containing protein | 0.0048 | 0.0087 | 0.0486 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.3512 | 1 | 1 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0046 | 0.008 | 0.008 |
Plasmodium falciparum | thioredoxin reductase | 0.0085 | 0.0194 | 0.0506 |
Plasmodium falciparum | chromodomain-helicase-DNA-binding protein 1 homolog, putative | 0.0023 | 0.0015 | 0.0033 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0042 | 0.0069 | 0.0177 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Echinococcus multilocularis | tubulin epsilon chain | 0.0384 | 0.1047 | 0.1047 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0066 | 0.0138 | 0.0275 |
Echinococcus granulosus | alpha tubulin | 0.0471 | 0.1297 | 0.1297 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.012 | 0.0292 | 0.0292 |
Entamoeba histolytica | tubulin gamma chain | 0.0384 | 0.1049 | 0.2231 |
Echinococcus multilocularis | tubulin delta chain | 0.0161 | 0.0411 | 0.0411 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0046 | 0.008 | 0.008 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0138 | 0.0344 | 0.0344 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.007 | 0.0151 | 0.0149 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.0092 | 0.009 |
Trichomonas vaginalis | tubulin beta-1 chain, putative | 0.0161 | 0.0411 | 0.0832 |
Trypanosoma brucei | zeta tubulin, putative | 0.0498 | 0.1375 | 0.1373 |
Leishmania major | DNA polymerase eta, putative | 0.007 | 0.0151 | 0.0148 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0088 | 0.0202 | 0.0426 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0055 | 0.0108 | 0.0236 |
Schistosoma mansoni | nocturnin | 0.0048 | 0.0087 | 0.0085 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.0494 | 0.0492 |
Giardia lamblia | hypothetical protein | 0.0048 | 0.0087 | 0.0486 |
Brugia malayi | tubulin alpha chain - mouse | 0.0471 | 0.1297 | 0.1295 |
Trichomonas vaginalis | Heterochromatin protein, putative | 0.0023 | 0.0015 | 0.0025 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0103 | 0.0244 | 0.0243 |
Loa Loa (eye worm) | endonuclease/Exonuclease/phosphatase | 0.0048 | 0.0087 | 0.0087 |
Schistosoma mansoni | carbonic anhydrase | 0.1339 | 0.3781 | 0.378 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0066 | 0.0138 | 0.0275 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.0034 | 0.0065 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0489 | 0.1348 | 0.1348 |
Giardia lamblia | Inositol 5-phosphatase 4 | 0.0048 | 0.0087 | 0.0486 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0194 | 0.0506 | 0.1522 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0625 | 0.1737 | 0.3534 |
Brugia malayi | aryl hydrocarbon receptor AHR-1 | 0.0124 | 0.0304 | 0.0302 |
Onchocerca volvulus | 0.019 | 0.0494 | 0.1394 | |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0046 | 0.008 | 0.0078 |
Trypanosoma cruzi | zeta tubulin, putative | 0.0498 | 0.1375 | 0.1373 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.018 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.0092 | 0.0092 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 0.019 | 0.0383 |
Entamoeba histolytica | chromodomain-helicase-DNA-binding protein, putative | 0.0023 | 0.0015 | 0.0027 |
Schistosoma mansoni | hypothetical protein | 0.034 | 0.0924 | 0.0923 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0216 | 0.0567 | 0.0566 |
Schistosoma mansoni | exonuclease | 0.0039 | 0.0062 | 0.006 |
Brugia malayi | Tubulin alpha chain | 0.0161 | 0.0411 | 0.0408 |
Mycobacterium leprae | cell division protein FtsZ | 0.0161 | 0.0411 | 0.0773 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0088 | 0.0202 | 0.0407 |
Trichomonas vaginalis | rotamase, putative | 0.0137 | 0.0341 | 0.069 |
Brugia malayi | Pin1-type peptidyl-prolyl cis-trans isomerase, BmPin1 | 0.0137 | 0.0341 | 0.0339 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.003 | 0.0034 | 0.0084 |
Trypanosoma cruzi | inositol 5-phosphatase 1, putative | 0.0048 | 0.0087 | 0.0084 |
Schistosoma mansoni | smad1 5 8 and | 0.0033 | 0.0045 | 0.0043 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0072 | 0.007 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0155 | 0.0392 | 0.1096 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0088 | 0.0202 | 0.0201 |
Echinococcus multilocularis | chromobox protein 1 | 0.0139 | 0.0349 | 0.0349 |
Plasmodium falciparum | tubulin gamma chain | 0.0384 | 0.1049 | 0.2769 |
Brugia malayi | N-terminal motif family protein | 0.0155 | 0.0392 | 0.039 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.004 | 0.0064 | 0.0062 |
Toxoplasma gondii | PPIC-type PPIASE domain-containing protein | 0.0042 | 0.0069 | 0.0175 |
Echinococcus multilocularis | lamin dm0 | 0.0084 | 0.019 | 0.019 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.0062 | 0.0059 |
Trypanosoma brucei | DNA damage repair protein, putative | 0.0043 | 0.0072 | 0.007 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.003 | 0.0034 | 0.0034 |
Echinococcus multilocularis | tumor protein p63 | 0.0703 | 0.1962 | 0.1962 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0025 | 0.0021 | 0.0019 |
Entamoeba histolytica | bacterial transferase hexapeptide family protein | 0.0046 | 0.0082 | 0.0169 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0194 | 0.0506 | 0.1522 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0108 |
Echinococcus multilocularis | tar DNA binding protein | 0.0054 | 0.0105 | 0.0105 |
Trypanosoma cruzi | tubulin gamma chain | 0.0384 | 0.1049 | 0.1046 |
Echinococcus granulosus | tar DNA binding protein | 0.0054 | 0.0105 | 0.0105 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1737 | 0.1736 |
Toxoplasma gondii | ABC1 family protein | 0.012 | 0.0292 | 0.0766 |
Giardia lamblia | Exonuclease 1 | 0.0039 | 0.0062 | 0.0341 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.019 | 0.0494 | 0.0494 |
Trypanosoma cruzi | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.004 | 0.0064 | 0.0061 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0139 | 0.0349 | 0.0349 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0085 | 0.0194 | 0.0194 |
Giardia lamblia | Alpha-tubulin | 0.0471 | 0.1297 | 0.7463 |
Brugia malayi | Thioredoxin reductase | 0.0085 | 0.0194 | 0.0191 |
Brugia malayi | tubulin alpha-2 chain | 0.0471 | 0.1297 | 0.1295 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0325 | 0.0881 | 0.0878 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0091 | 0.0211 | 0.0424 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0096 | 0.0225 | 0.0373 |
Plasmodium falciparum | carbon catabolite repressor protein 4, putative | 0.0048 | 0.0087 | 0.0223 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.003 | 0.0034 | 0.0084 |
Onchocerca volvulus | 0.0031 | 0.0038 | 0.0068 | |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0223 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.009 | 0.0207 | 0.0437 |
Echinococcus granulosus | carbonic anhydrase | 0.1339 | 0.3781 | 0.3781 |
Trypanosoma brucei | Sulfate transporter N-terminal domain with GLY motif/Sulfate transporter family, putative | 0.0037 | 0.0056 | 0.0054 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.012 | 0.0292 | 0.0292 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.1076 | 0.3029 | 0.3029 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0746 | 0.2085 | 0.2085 |
Schistosoma mansoni | ets-related | 0.0237 | 0.0627 | 0.0626 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0441 | 0.121 | 0.121 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0085 | 0.0194 | 0.0194 |
Trypanosoma brucei | alpha tubulin, putative | 0.019 | 0.0494 | 0.0492 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0212 | 0.0558 | 0.0556 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0049 | 0.0049 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.012 | 0.0292 | 0.029 |
Brugia malayi | MH1 domain containing protein | 0.0033 | 0.0045 | 0.0043 |
Echinococcus granulosus | lamin | 0.0084 | 0.019 | 0.019 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0172 | 0.0443 | 0.0441 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.019 | 0.0494 | 0.0492 |
Loa Loa (eye worm) | hypothetical protein | 0.034 | 0.0924 | 0.0924 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0292 | 0.0292 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0039 | 0.0062 | 0.0121 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.012 | 0.0292 | 0.0831 |
Plasmodium falciparum | glutathione reductase | 0.003 | 0.0034 | 0.0084 |
Echinococcus granulosus | Chromobox protein 3 | 0.0023 | 0.0015 | 0.0015 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0046 | 0.008 | 0.0078 |
Entamoeba histolytica | Flap nuclease, putative | 0.0193 | 0.0501 | 0.1063 |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0223 |
Onchocerca volvulus | 0.012 | 0.0292 | 0.0805 | |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 0.5642 |
Toxoplasma gondii | alpha tubulin TUBA1 | 0.0471 | 0.1297 | 0.3426 |
Trypanosoma cruzi | mitochondrial protein 99, putative | 0.0048 | 0.0087 | 0.0084 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0351 | 0.0955 | 0.1941 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0061 | 0.0061 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.003 | 0.0034 | 0.0084 |
Echinococcus granulosus | tubulin beta 1 chain | 0.0625 | 0.1737 | 0.1737 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0036 | 0.0052 | 0.0057 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0194 | 0.0506 | 0.1522 |
Trichomonas vaginalis | ocrl type II inositol 5-phosphatase, putative | 0.0048 | 0.0087 | 0.0172 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0091 | 0.0211 | 0.0211 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Echinococcus multilocularis | tubulin subunit TubB | 0.0471 | 0.1297 | 0.1297 |
Schistosoma mansoni | chromobox protein-related (chromobox 1) (heterochromatin 1) | 0.0023 | 0.0015 | 0.0013 |
Schistosoma mansoni | smad | 0.0033 | 0.0045 | 0.0043 |
Trichomonas vaginalis | chromobox protein, putative | 0.0023 | 0.0015 | 0.0025 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0033 | 0.0045 | 0.0045 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0052 | 0.0099 | 0.0197 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0237 | 0.0628 | 0.1275 |
Loa Loa (eye worm) | intermediate filament protein | 0.0084 | 0.019 | 0.019 |
Trypanosoma cruzi | Inositol phosphosphingolipids phospholipase C | 0.0048 | 0.0087 | 0.0084 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0055 | 0.0108 | 0.0105 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0072 | 0.007 |
Brugia malayi | jmjC domain containing protein | 0.0063 | 0.0131 | 0.0129 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.004 | 0.0064 | 0.0125 |
Echinococcus granulosus | expressed conserved protein | 0.02 | 0.0521 | 0.0521 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.0086 | 0.0171 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.012 | 0.0292 | 0.059 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0022 | 0.0012 | 0.0009 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.0034 | 0.0065 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0046 | 0.008 | 0.0159 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.003 | 0.0034 | 0.0032 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Toxoplasma gondii | peptidylprolyl isomerase | 0.0134 | 0.0332 | 0.0873 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Entamoeba histolytica | hypothetical protein | 0.002 | 0.0008 | 0.0011 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0046 | 0.008 | 0.0078 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0078 | 0.0173 | 0.0173 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0193 | 0.0501 | 0.0501 |
Entamoeba histolytica | hypothetical protein | 0.019 | 0.0494 | 0.1048 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0054 | 0.0105 | 0.0102 |
Toxoplasma gondii | 'chromo' (CHRromatin Organization MOdifier) domain-containing protein | 0.0023 | 0.0015 | 0.0033 |
Trypanosoma cruzi | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Toxoplasma gondii | BRCA1 C Terminus (BRCT) domain-containing protein | 0.0077 | 0.0171 | 0.0446 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0039 | 0.0062 | 0.0157 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0039 | 0.0062 | 0.0121 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0066 | 0.0138 | 0.0358 |
Loa Loa (eye worm) | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Echinococcus multilocularis | bloom syndrome protein | 0.0023 | 0.0015 | 0.0015 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0088 | 0.0202 | 0.0407 |
Trichomonas vaginalis | chromobox protein, putative | 0.0139 | 0.0349 | 0.0705 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0066 | 0.0139 | 0.0137 |
Plasmodium vivax | DNA repair protein REV1, putative | 0.0043 | 0.0072 | 0.0402 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0108 | 0.0215 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0277 | 0.0742 | 0.074 |
Echinococcus granulosus | tubulin alpha 1C chain | 0.0471 | 0.1297 | 0.1297 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.1113 | 0.3135 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0084 | 0.019 | 0.019 |
Brugia malayi | PAS domain containing protein | 0.0066 | 0.0137 | 0.0135 |
Echinococcus granulosus | chromobox protein 1 | 0.0139 | 0.0349 | 0.0349 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0033 | 0.0045 | 0.0045 |
Schistosoma mansoni | ocrl type II inositol 5-phosphatase | 0.0048 | 0.0087 | 0.0085 |
Plasmodium falciparum | carbon catabolite repressor protein 4, putative | 0.0048 | 0.0087 | 0.0223 |
Schistosoma mansoni | tar DNA-binding protein | 0.0054 | 0.0105 | 0.0103 |
Entamoeba histolytica | chromodomain-helicase-DNA-binding protein, putative | 0.0023 | 0.0015 | 0.0027 |
Schistosoma mansoni | chromobox protein-related (chromobox 1) (heterochromatin 1) | 0.0023 | 0.0015 | 0.0013 |
Echinococcus multilocularis | protein patched | 0.0091 | 0.0211 | 0.0211 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0023 | 0.0015 | 0.0025 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0106 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.0086 | 0.0171 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase | 0.0042 | 0.0069 | 0.0066 |
Trypanosoma cruzi | DNA damage repair protein, putative | 0.0043 | 0.0072 | 0.007 |
Plasmodium vivax | delta tubulin, putative | 0.0161 | 0.0411 | 0.2354 |
Mycobacterium tuberculosis | Probable exported protein | 0.0048 | 0.0087 | 0.0169 |
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0046 | 0.008 | 0.045 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.0369 | 0.0369 |
Trypanosoma brucei | DNA damage repair protein, putative | 0.0043 | 0.0072 | 0.007 |
Loa Loa (eye worm) | tubulin beta chain | 0.0625 | 0.1737 | 0.1737 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Plasmodium vivax | exodeoxyribonuclease III, putative | 0.0048 | 0.0087 | 0.0486 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0165 | 0.0423 | 0.0421 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0161 | 0.0411 | 0.0832 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0015 | 0.0027 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0046 | 0.008 | 0.0159 |
Brugia malayi | RNA, U transporter 1 | 0.0071 | 0.0154 | 0.0151 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0066 | 0.0139 | 0.0139 |
Trichomonas vaginalis | tubulin, putative | 0.0625 | 0.1737 | 0.3534 |
Echinococcus multilocularis | carbonic anhydrase | 0.1339 | 0.3781 | 0.3781 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0212 | 0.0558 | 0.0558 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.3512 | 1 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0325 | 0.0881 | 0.0878 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0042 | 0.0069 | 0.0067 |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0223 |
Toxoplasma gondii | beta tubulin | 0.0625 | 0.1737 | 0.4591 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0.0082 | 0.0079 |
Trypanosoma brucei | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | MH2 domain containing protein | 0.0033 | 0.0045 | 0.0043 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 0.0687 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0078 | 0.0173 | 0.0173 |
Schistosoma mansoni | smad1 5 8 and | 0.0033 | 0.0045 | 0.0043 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Schistosoma mansoni | smad1 5 8 and | 0.0033 | 0.0045 | 0.0043 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.047 | 0.047 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Leishmania major | carbonic anhydrase family protein, putative | 0.1657 | 0.4691 | 0.469 |
Schistosoma mansoni | cript-related | 0.0048 | 0.0087 | 0.0085 |
Echinococcus granulosus | tubulin alpha | 0.0351 | 0.0955 | 0.0955 |
Trichomonas vaginalis | importin beta-1, putative | 0.002 | 0.0008 | 0.0011 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0268 | 0.0715 | 0.0715 |
Trypanosoma brucei | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0137 | 0.0341 | 0.069 |
Schistosoma mansoni | hypothetical protein | 0.034 | 0.0924 | 0.0923 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0096 | 0.0225 | 0.0615 |
Leishmania major | gamma-tubulin | 0.0384 | 0.1049 | 0.1046 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0046 | 0.008 | 0.0078 |
Loa Loa (eye worm) | endonuclease/Exonuclease/phosphatase | 0.0048 | 0.0087 | 0.0087 |
Onchocerca volvulus | 0.0272 | 0.0727 | 0.2071 | |
Brugia malayi | Protein cec-1. | 0.0023 | 0.0015 | 0.0013 |
Schistosoma mansoni | hypothetical protein | 0.034 | 0.0924 | 0.0923 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0239 | 0.0633 | 0.0633 |
Loa Loa (eye worm) | hypothetical protein | 0.0165 | 0.0423 | 0.0423 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.089 | 0.2498 | 0.7944 |
Loa Loa (eye worm) | beta-tubulin | 0.0625 | 0.1737 | 0.1737 |
Trypanosoma cruzi | Sulfate transporter N-terminal domain with GLY motif/Sulfate transporter family, putative | 0.0037 | 0.0056 | 0.0054 |
Mycobacterium ulcerans | cell division protein FtsZ | 0.0161 | 0.0411 | 0.0772 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1339 | 0.3781 | 0.3781 |
Echinococcus multilocularis | dna polymerase eta | 0.0165 | 0.0423 | 0.0423 |
Loa Loa (eye worm) | BEN-1 protein | 0.0625 | 0.1737 | 0.1737 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Schistosoma mansoni | carbonic anhydrase-related | 0.1339 | 0.3781 | 0.378 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.018 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0172 | 0.0443 | 0.0441 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.002 | 0.0008 | 0.0011 |
Plasmodium falciparum | inorganic anion exchanger, inorganic anion antiporter | 0.0037 | 0.0056 | 0.0142 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0033 | 0.0045 | 0.0045 |
Brugia malayi | beta-lactamase | 0.012 | 0.0292 | 0.029 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Schistosoma mansoni | tubulin subunit delta | 0.0161 | 0.0411 | 0.0409 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.007 | 0.0151 | 0.0302 |
Schistosoma mansoni | cpg binding protein | 0.0033 | 0.0043 | 0.0042 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.007 | 0.0151 | 0.0392 |
Trypanosoma cruzi | importin beta-1 subunit, putative | 0.002 | 0.0008 | 0.0005 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0237 | 0.0628 | 0.3609 |
Trichomonas vaginalis | exonuclease%2C+putative | 0.0039 | 0.0062 | 0.0121 |
Brugia malayi | follicle stimulating hormone receptor | 0.0268 | 0.0715 | 0.0713 |
Leishmania major | peptidyl-prolyl cis-trans isomerase/rotamase, putative,PPIase, putative | 0.0134 | 0.0332 | 0.033 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.012 | 0.0292 | 0.0292 |
Trypanosoma cruzi | tubulin delta chain | 0.0363 | 0.0987 | 0.0985 |
Plasmodium falciparum | importin beta, putative | 0.0025 | 0.0021 | 0.005 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0019 | 0.0003 | 0.0003 |
Echinococcus granulosus | traf and tnf receptor associated protein | 0.0048 | 0.0087 | 0.0087 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0066 | 0.0139 | 0.0338 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0066 | 0.0138 | 0.0275 |
Echinococcus granulosus | flap endonuclease 1 | 0.0193 | 0.0501 | 0.0501 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0141 | 0.0141 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0237 | 0.0628 | 1 |
Trypanosoma brucei | DNA repair protein RAD2, putative | 0.0039 | 0.0062 | 0.0059 |
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | 0.008 | 0.018 | 0.2453 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.004 | 0.0064 | 0.0064 |
Loa Loa (eye worm) | tubulin beta-1 chain | 0.0625 | 0.1737 | 0.1737 |
Mycobacterium tuberculosis | Probable hydrolase | 0.012 | 0.0292 | 0.0831 |
Giardia lamblia | Delta tubulin | 0.0161 | 0.0411 | 0.2354 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0172 | 0.0443 | 0.1319 |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0223 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0035 | 0.0049 | 0.0049 |
Onchocerca volvulus | Putative sulfate transporter | 0.0234 | 0.0619 | 0.1755 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.003 | 0.0034 | 0.0032 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.007 | 0.0151 | 0.0149 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0237 | 0.0628 | 0.0628 |
Giardia lamblia | GTOR | 0.0088 | 0.0202 | 0.1153 |
Entamoeba histolytica | hypothetical protein | 0.019 | 0.0494 | 0.1048 |
Plasmodium vivax | SET domain protein, putative | 0.0035 | 0.0049 | 0.027 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0023 | 0.0015 | 0.0026 |
Echinococcus granulosus | neutral sphingomyelinase | 0.0048 | 0.0087 | 0.0087 |
Loa Loa (eye worm) | alpha-tubulin | 0.0471 | 0.1297 | 0.1297 |
Echinococcus multilocularis | musashi | 0.0084 | 0.019 | 0.019 |
Trichomonas vaginalis | hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Schistosoma mansoni | tar DNA-binding protein | 0.0054 | 0.0105 | 0.0103 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Plasmodium vivax | hypothetical protein, conserved | 0.0023 | 0.0015 | 0.0072 |
Loa Loa (eye worm) | endonuclease/Exonuclease/phosphatase | 0.0048 | 0.0087 | 0.0087 |
Trypanosoma brucei | beta tubulin | 0.0351 | 0.0955 | 0.0953 |
Brugia malayi | RNA binding protein | 0.0054 | 0.0105 | 0.0102 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0489 | 0.1348 | 0.1348 |
Trypanosoma cruzi | tubulin delta chain | 0.0363 | 0.0987 | 0.0985 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0046 | 0.0081 | 0.0078 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0091 | 0.0211 | 0.0211 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0039 | 0.0062 | 0.0121 |
Schistosoma mansoni | hypothetical protein | 0.0736 | 0.2055 | 0.2053 |
Plasmodium falciparum | DNA repair protein RAD2, putative | 0.0039 | 0.0062 | 0.0157 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0092 | 0.0091 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.019 | 0.019 |
Loa Loa (eye worm) | fli-1 protein | 0.0237 | 0.0627 | 0.0627 |
Echinococcus multilocularis | traf and tnf receptor associated protein | 0.0048 | 0.0087 | 0.0087 |
Echinococcus granulosus | aryl hydrocarbon receptor | 0.0141 | 0.0355 | 0.0355 |
Plasmodium falciparum | glutathione reductase | 0.0085 | 0.0194 | 0.0506 |
Brugia malayi | Tubulin alpha-2 chain | 0.0471 | 0.1297 | 0.1295 |
Trypanosoma brucei | Inositol phosphosphingolipids phospholipase C | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | hypothetical protein | 0.0042 | 0.0069 | 0.0067 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0088 | 0.0202 | 0.0202 |
Brugia malayi | Cell division protein ftsZ | 0.0161 | 0.0411 | 0.0408 |
Echinococcus multilocularis | hypothetical protein | 0.0471 | 0.1297 | 0.1297 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0039 | 0.0062 | 0.0157 |
Trichomonas vaginalis | tubulin, putative | 0.019 | 0.0494 | 0.1002 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0147 | 0.0369 | 0.0684 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0033 | 0.0044 | 0.0044 |
Echinococcus granulosus | beta tubulin | 0.0625 | 0.1737 | 0.1737 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0015 | 0.0027 |
Schistosoma mansoni | single-minded | 0.0066 | 0.0137 | 0.0136 |
Brugia malayi | Isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0105 |
Schistosoma mansoni | lamin | 0.0084 | 0.019 | 0.0188 |
Entamoeba histolytica | hypothetical protein | 0.019 | 0.0494 | 0.1048 |
Toxoplasma gondii | beta-tubulin, putative | 0.0625 | 0.1737 | 0.4591 |
Onchocerca volvulus | 0.0049 | 0.009 | 0.0218 | |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0237 | 0.0628 | 0.0626 |
Trypanosoma brucei | epsilon tubulin | 0.0351 | 0.0955 | 0.0953 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0042 | 0.0069 | 0.0177 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0216 | 0.0568 | 0.1722 |
Echinococcus multilocularis | peroxisome assembly protein 26 | 0.0471 | 0.1297 | 0.1297 |
Trypanosoma brucei | DNA polymerase beta thumb, putative | 0.0046 | 0.0081 | 0.0078 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Schistosoma mansoni | importin beta-1 | 0.0025 | 0.0021 | 0.002 |
Echinococcus multilocularis | tubulin subunit beta | 0.0625 | 0.1737 | 0.1737 |
Schistosoma mansoni | jumonji domain containing protein | 0.0063 | 0.0131 | 0.0129 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0015 | 0.0015 |
Loa Loa (eye worm) | beta-lactamase | 0.012 | 0.0292 | 0.0292 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0062 | 0.0062 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0066 | 0.0138 | 0.0275 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Echinococcus multilocularis | Tubulin alpha 1 chain | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.019 | 0.0494 | 0.1002 |
Leishmania major | DNA polymerase kappa, putative | 0.0172 | 0.0443 | 0.0441 |
Mycobacterium ulcerans | beta-lactamase | 0.012 | 0.0292 | 0.0529 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Brugia malayi | beta-lactamase family protein | 0.012 | 0.0292 | 0.029 |
Mycobacterium tuberculosis | Conserved protein | 0.012 | 0.0292 | 0.0831 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.019 | 0.0494 | 0.0494 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.009 | 0.0207 | 0.0437 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.0086 | 0.0171 |
Onchocerca volvulus | 0.0048 | 0.0087 | 0.0209 | |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.004 | 0.0065 | 0.0065 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0055 | 0.0108 | 0.0108 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0015 | 0.0015 |
Mycobacterium ulcerans | integral membrane transporter | 0.0037 | 0.0056 | 0.0045 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0182 | 0.047 | 0.0468 |
Loa Loa (eye worm) | hypothetical protein | 0.1339 | 0.3781 | 0.3781 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0035 | 0.0049 | 0.0124 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0088 | 0.0202 | 0.02 |
Trichomonas vaginalis | type IV inositol 5-phosphatase, putative | 0.0048 | 0.0087 | 0.0172 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0055 | 0.0108 | 0.0105 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0193 | 0.0501 | 0.0498 |
Brugia malayi | intermediate filament protein | 0.0084 | 0.019 | 0.0187 |
Giardia lamblia | Beta tubulin | 0.0625 | 0.1737 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0069 | 0.0069 |
Onchocerca volvulus | Huntingtin homolog | 0.0132 | 0.0327 | 0.0908 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0072 | 0.007 |
Echinococcus granulosus | chromobox protein 1 | 0.0139 | 0.0349 | 0.0349 |
Entamoeba histolytica | exonuclease, putative | 0.0039 | 0.0062 | 0.0126 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0058 | 0.0115 | 0.0113 |
Loa Loa (eye worm) | XPG I-region family protein | 0.0039 | 0.0062 | 0.0062 |
Echinococcus granulosus | tubulin subunit beta | 0.0625 | 0.1737 | 0.1737 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.003 | 0.0034 | 0.0183 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0063 | 0.0131 | 0.0131 |
Schistosoma mansoni | gabp alpha | 0.0078 | 0.0173 | 0.0171 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Trypanosoma cruzi | zeta tubulin, putative | 0.0498 | 0.1375 | 0.1373 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase/rotamase, putative | 0.0134 | 0.0332 | 0.033 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.3512 | 1 | 1 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.003 | 0.0034 | 0.0183 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.004 | 0.0064 | 0.0062 |
Leishmania major | protein kinase, putative | 0.002 | 0.0008 | 0.0005 |
Plasmodium vivax | endonuclease, putative | 0.0021 | 0.0009 | 0.0036 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0216 | 0.0568 | 0.1113 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0052 | 0.0099 | 0.0197 |
Trichomonas vaginalis | rotamase, putative | 0.0134 | 0.0332 | 0.0672 |
Brugia malayi | Tubulin beta-1 chain | 0.0625 | 0.1737 | 0.1735 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.003 | 0.0034 | 0.0183 |
Entamoeba histolytica | tubulin family protein | 0.0625 | 0.1737 | 0.37 |
Giardia lamblia | Beta tubulin | 0.0625 | 0.1737 | 1 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Onchocerca volvulus | 0.0058 | 0.0115 | 0.029 | |
Mycobacterium ulcerans | lipase LipD | 0.012 | 0.0292 | 0.0529 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0092 | 0.0092 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.012 | 0.0292 | 0.0831 |
Entamoeba histolytica | inositol polyphosphate-5-phosphatase, putative | 0.0048 | 0.0087 | 0.018 |
Toxoplasma gondii | thioredoxin reductase | 0.0085 | 0.0194 | 0.0506 |
Loa Loa (eye worm) | hypothetical protein | 0.031 | 0.0836 | 0.0836 |
Trypanosoma brucei | chrX additional, unordered contigs | 0.0043 | 0.0072 | 0.007 |
Leishmania major | zeta tubulin, putative | 0.0498 | 0.1375 | 0.1373 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.0017 | 0.0031 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.003 | 0.0034 | 0.0032 |
Loa Loa (eye worm) | hypothetical protein | 0.0471 | 0.1297 | 0.1297 |
Plasmodium falciparum | heterochromatin protein 1 | 0.0023 | 0.0015 | 0.0033 |
Onchocerca volvulus | 0.0077 | 0.0171 | 0.0454 | |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0003 | 0.0002 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Schistosoma mansoni | patched 1 | 0.0091 | 0.0211 | 0.0209 |
Trypanosoma brucei | zeta tubulin | 0.0498 | 0.1375 | 0.1373 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0088 | 0.0202 | 0.02 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0212 | 0.0558 | 0.0558 |
Echinococcus multilocularis | beta tubulin | 0.0625 | 0.1737 | 0.1737 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0091 | 0.0211 | 0.0211 |
Schistosoma mansoni | chromodomain helicase DNA binding protein | 0.0023 | 0.0015 | 0.0013 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0015 | 0.0015 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1734 | 0.4911 | 1 |
Mycobacterium tuberculosis | Cell division protein FtsZ | 0.0161 | 0.0411 | 0.1214 |
Trypanosoma cruzi | RNA-editing complex protein MP100, putative | 0.0048 | 0.0087 | 0.0084 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.0003 | 0.0001 |
Mycobacterium leprae | Probable lipase LipE | 0.012 | 0.0292 | 0.0517 |
Loa Loa (eye worm) | hypothetical protein | 0.0324 | 0.0876 | 0.0876 |
Loa Loa (eye worm) | CHromoDomain protein family member | 0.0025 | 0.002 | 0.002 |
Loa Loa (eye worm) | hypothetical protein | 0.1225 | 0.3454 | 0.3454 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0087 | 0.0087 |
Toxoplasma gondii | chromodomain helicase DNA binding protein CHD1/SWI2/SNF2 | 0.0023 | 0.0015 | 0.0033 |
Loa Loa (eye worm) | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0066 | 0.0138 | 0.0275 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 0.5642 |
Brugia malayi | Ets-domain containing protein | 0.0078 | 0.0173 | 0.0171 |
Leishmania major | pantothenate kinase subunit, putative | 0.0048 | 0.0087 | 0.0084 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0147 | 0.0369 | 0.2116 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1297 | 0.2637 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 1 |
Schistosoma mansoni | alpha tubulin | 0.0471 | 0.1297 | 0.1296 |
Schistosoma mansoni | tar DNA-binding protein | 0.0054 | 0.0105 | 0.0103 |
Echinococcus granulosus | tubulin epsilon chain | 0.0384 | 0.1047 | 0.1047 |
Brugia malayi | Flap endonuclease-1 | 0.0193 | 0.0501 | 0.0498 |
Echinococcus granulosus | tubulin delta chain | 0.0161 | 0.0411 | 0.0411 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0.0082 | 0.0079 |
Echinococcus granulosus | dynactin 5 p25 | 0.008 | 0.018 | 0.018 |
Echinococcus multilocularis | inositol polyphosphate 5 phosphatase OCRL 1 | 0.0048 | 0.0087 | 0.0087 |
Trypanosoma brucei | hypothetical protein, conserved | 0.012 | 0.0292 | 0.029 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase | 0.0134 | 0.0332 | 0.033 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1657 | 0.4691 | 0.9549 |
Toxoplasma gondii | tubulin/FtsZ family, GTPase domain-containing protein | 0.0363 | 0.0987 | 0.2607 |
Toxoplasma gondii | inorganic anion transporter, sulfate permease (SulP) family protein | 0.0037 | 0.0056 | 0.0142 |
Echinococcus granulosus | dna polymerase kappa | 0.0277 | 0.0742 | 0.0742 |
Trypanosoma brucei | unspecified product | 0.0243 | 0.0644 | 0.0641 |
Plasmodium falciparum | thioredoxin reductase | 0.003 | 0.0034 | 0.0084 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0384 | 0.1047 | 0.1045 |
Entamoeba histolytica | ankyrin, putative | 0.008 | 0.018 | 0.0379 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0043 | 0.0072 | 0.0185 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.004 | 0.0064 | 0.0125 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0088 | 0.0202 | 0.02 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0046 | 0.008 | 0.008 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0002 | 0.0002 |
Trypanosoma cruzi | pantothenate kinase subunit, putative | 0.0048 | 0.0087 | 0.0084 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0182 | 0.047 | 0.0468 |
Echinococcus multilocularis | carbonic anhydrase II | 0.3512 | 1 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 0.019 | 0.0383 |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0223 |
Schistosoma mansoni | xp-G/rad2 DNA repair endonuclease family | 0.0039 | 0.0062 | 0.006 |
Brugia malayi | MH2 domain containing protein | 0.0489 | 0.1348 | 0.1346 |
Schistosoma mansoni | tubulin subunit alpha | 0.0471 | 0.1297 | 0.1296 |
Loa Loa (eye worm) | hypothetical protein | 0.0212 | 0.0558 | 0.0558 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Brugia malayi | beta-tubulin, identical | 0.0625 | 0.1737 | 0.1735 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase domain containing protein | 0.0048 | 0.0087 | 0.018 |
Echinococcus granulosus | tubulin alpha 3 chain | 0.0471 | 0.1297 | 0.1297 |
Echinococcus granulosus | Tubulin alpha 1 chain | 0.0471 | 0.1297 | 0.1297 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0237 | 0.0628 | 0.0626 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.004 | 0.0064 | 0.0062 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.3512 | 1 | 1 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.3512 | 1 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0132 | 0.0327 | 0.0908 |
Plasmodium vivax | tubulin alpha chain, putative | 0.0471 | 0.1297 | 0.7463 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.012 | 0.0292 | 0.059 |
Echinococcus multilocularis | tubulin alpha 1C chain | 0.0471 | 0.1297 | 0.1297 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0046 | 0.008 | 0.008 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.007 | 0.0151 | 0.0302 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0237 | 0.0628 | 0.1916 |
Loa Loa (eye worm) | hypothetical protein | 0.0141 | 0.0353 | 0.0353 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Schistosoma mansoni | inositol monophosphatase | 0.004 | 0.0064 | 0.0062 |
Leishmania major | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Echinococcus multilocularis | carbonic anhydrase | 0.1339 | 0.3781 | 0.3781 |
Brugia malayi | Heterochromatin protein 1 | 0.0139 | 0.0349 | 0.0346 |
Echinococcus granulosus | inositol polyphosphate 5 phosphatase OCRL 1 | 0.0048 | 0.0087 | 0.0087 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.034 | 0.0924 | 0.0924 |
Mycobacterium tuberculosis | Possible siderophore-binding protein | 0.0046 | 0.0082 | 0.0153 |
Echinococcus granulosus | intermediate filament protein | 0.0084 | 0.019 | 0.019 |
Echinococcus granulosus | CCR4 NOT transcription complex subunit 6 | 0.0048 | 0.0087 | 0.0087 |
Plasmodium vivax | heterochromatin protein 1, putative | 0.0023 | 0.0015 | 0.0072 |
Trypanosoma brucei | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Loa Loa (eye worm) | inositol-1 | 0.004 | 0.0064 | 0.0064 |
Wolbachia endosymbiont of Brugia malayi | parvulin-like peptidyl-prolyl isomerase, PPID | 0.0042 | 0.0069 | 0.0581 |
Echinococcus granulosus | GTP binding nuclear protein Ran | 0.0018 | 0.0002 | 0.0002 |
Treponema pallidum | cell division protein FtsZ | 0.0161 | 0.0411 | 0.6337 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Echinococcus multilocularis | cpg binding protein | 0.0033 | 0.0043 | 0.0043 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0108 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Toxoplasma gondii | tubulin/FtsZ family, GTPase domain-containing protein | 0.0193 | 0.0503 | 0.1324 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0138 | 0.0344 | 0.0343 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.3512 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0015 | 0.0015 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.013 | 0.0321 | 0.0318 |
Echinococcus multilocularis | lamin | 0.0084 | 0.019 | 0.019 |
Echinococcus granulosus | GPCR family 2 | 0.034 | 0.0924 | 0.0924 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0023 | 0.0015 | 0.0025 |
Echinococcus multilocularis | Chromobox protein 3 | 0.0023 | 0.0015 | 0.0015 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0035 | 0.0049 | 0.0048 |
Echinococcus multilocularis | dna polymerase kappa | 0.0277 | 0.0742 | 0.0742 |
Brugia malayi | polk-prov protein | 0.0182 | 0.047 | 0.0468 |
Echinococcus multilocularis | tubulin alpha 3 chain | 0.0471 | 0.1297 | 0.1297 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.0139 | 0.0137 |
Brugia malayi | Pre-SET motif family protein | 0.0239 | 0.0633 | 0.0631 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 0.0687 |
Brugia malayi | Latrophilin receptor protein 2 | 0.034 | 0.0924 | 0.0922 |
Trypanosoma cruzi | Endonuclease/Exonuclease/phosphatase family, putative | 0.0048 | 0.0087 | 0.0084 |
Loa Loa (eye worm) | hypothetical protein | 0.0324 | 0.0876 | 0.0876 |
Brugia malayi | GTP-binding nuclear protein RAN/TC4 | 0.0018 | 0.0002 | 0.0000081665 |
Trypanosoma cruzi | mitochondrial protein 99, putative | 0.0048 | 0.0087 | 0.0084 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.012 | 0.0292 | 0.029 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Schistosoma mansoni | ap endonuclease | 0.0237 | 0.0628 | 0.0627 |
Echinococcus granulosus | exonuclease 1 | 0.0039 | 0.0062 | 0.0062 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0048 | 0.0087 | 0.0172 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0023 | 0.0015 | 0.0025 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0042 | 0.0069 | 0.0067 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 0.0971 |
Brugia malayi | Importin beta-1 subunit | 0.0025 | 0.0021 | 0.0019 |
Trypanosoma brucei | tubulin delta chain | 0.0363 | 0.0987 | 0.0985 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0161 | 0.0411 | 0.0832 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0046 | 0.0081 | 0.0078 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0384 | 0.1047 | 0.1045 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0088 | 0.0202 | 0.0407 |
Echinococcus granulosus | single minded 2 | 0.0048 | 0.0088 | 0.0088 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1657 | 0.4691 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0088 | 0.0202 | 0.02 |
Echinococcus multilocularis | Tubulin alpha 1 chain | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | chromobox protein, putative | 0.0023 | 0.0015 | 0.0025 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0502 | 0.1386 | 0.1386 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Mycobacterium ulcerans | hypothetical protein | 0.0171 | 0.044 | 0.0832 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.003 | 0.0034 | 0.0032 |
Trypanosoma cruzi | alpha tubulin, putative | 0.0471 | 0.1297 | 0.1295 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0046 | 0.008 | 0.0078 |
Echinococcus multilocularis | tubulin beta 1 chain | 0.0625 | 0.1737 | 0.1737 |
Echinococcus multilocularis | expressed protein | 0.0137 | 0.0341 | 0.0341 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0002 | 0.0002 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.034 | 0.0924 | 0.0922 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0051 | 0.0094 | 0.0529 |
Schistosoma mansoni | chromodomain helicase DNA binding protein | 0.0025 | 0.002 | 0.0018 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.018 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.0281 | 0.0752 | 0.1528 |
Echinococcus granulosus | Tubulin alpha 1 chain | 0.0471 | 0.1297 | 0.1297 |
Entamoeba histolytica | hypothetical protein | 0.019 | 0.0494 | 0.1048 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Schistosoma mansoni | Smad4 | 0.0033 | 0.0045 | 0.0043 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.003 | 0.0034 | 0.0032 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Entamoeba histolytica | acetyltransferase, putative | 0.008 | 0.018 | 0.0379 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0325 | 0.0881 | 0.0878 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0277 | 0.0742 | 0.074 |
Giardia lamblia | DNA damage repair protein | 0.0043 | 0.0072 | 0.0402 |
Entamoeba histolytica | sphingomyelinase C precursor, putative | 0.0048 | 0.0087 | 0.018 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 0.0369 |
Schistosoma mansoni | synaptojanin | 0.0048 | 0.0087 | 0.0085 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0625 | 0.1737 | 0.3534 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0078 | 0.0173 | 0.046 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0085 | 0.0194 | 0.0194 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0277 | 0.0742 | 0.1507 |
Schistosoma mansoni | tar DNA-binding protein | 0.0054 | 0.0105 | 0.0103 |
Brugia malayi | hypothetical protein | 0.1225 | 0.3454 | 0.3452 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.003 | 0.0034 | 0.0034 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1737 | 0.1736 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0194 | 0.0506 | 0.1522 |
Loa Loa (eye worm) | endonuclease/Exonuclease/phosphatase | 0.0048 | 0.0087 | 0.0087 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.018 |
Schistosoma mansoni | hypothetical protein | 0.0023 | 0.0015 | 0.0013 |
Leishmania major | importin beta-1 subunit, putative | 0.002 | 0.0008 | 0.0005 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Plasmodium falciparum | DNA repair protein REV1, putative | 0.0043 | 0.0072 | 0.0185 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0304 | 0.0819 | 0.0819 |
Trichomonas vaginalis | chromobox protein, putative | 0.0023 | 0.0015 | 0.0025 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0054 | 0.0105 | 0.0105 |
Schistosoma mansoni | tubulin subunit alpha | 0.0471 | 0.1297 | 0.1296 |
Leishmania major | carbonic anhydrase-like protein | 0.3512 | 1 | 1 |
Echinococcus multilocularis | CCR4 NOT transcription complex subunit 6 | 0.0048 | 0.0087 | 0.0087 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0471 | 0.1297 | 0.2637 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Wolbachia endosymbiont of Brugia malayi | carbonic anhydrase | 0.0046 | 0.0082 | 0.08 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.0306 | 0.0306 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0216 | 0.0568 | 0.1722 |
Plasmodium vivax | sulfate transporter, putative | 0.0037 | 0.0056 | 0.031 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0237 | 0.0628 | 0.3609 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0237 | 0.0628 | 0.0628 |
Loa Loa (eye worm) | hypothetical protein | 0.0132 | 0.0327 | 0.0327 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0015 | 0.0027 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0027 | 0.0026 | 0.0047 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0277 | 0.0742 | 0.1452 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0138 | 0.0344 | 0.0342 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0625 | 0.1737 | 0.3534 |
Plasmodium vivax | exonuclease I, putative | 0.0039 | 0.0062 | 0.0341 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0193 | 0.0501 | 0.0498 |
Brugia malayi | Type III restriction enzyme, res subunit family protein | 0.0023 | 0.0015 | 0.0013 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Plasmodium vivax | tubulin epsilon chain, putative | 0.0384 | 0.1047 | 0.6023 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.004 | 0.0064 | 0.0131 |
Leishmania major | inositol phosphosphingolipid phospholipase C-Like | 0.0048 | 0.0087 | 0.0084 |
Loa Loa (eye worm) | hypothetical protein | 0.0736 | 0.2055 | 0.2055 |
Onchocerca volvulus | 0.0141 | 0.0353 | 0.0983 | |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1297 | 0.2637 |
Onchocerca volvulus | 0.0084 | 0.019 | 0.0508 | |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0051 | 0.0094 | 0.0243 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.046 | 0.1267 | 0.1267 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0042 | 0.0069 | 0.0067 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0292 | 0.0292 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.012 | 0.0292 | 0.0529 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0075 | 0.0165 | 0.0332 |
Trypanosoma cruzi | DNA damage repair protein, putative | 0.0043 | 0.0072 | 0.007 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0237 | 0.0628 | 0.1657 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.0042 | 0.0069 | 0.0066 |
Trichomonas vaginalis | glutathione reductase, putative | 0.003 | 0.0034 | 0.0065 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.3512 | 1 | 1 |
Loa Loa (eye worm) | tubulin beta-4 chain | 0.0625 | 0.1737 | 0.1737 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0026 | 0.0024 | 0.0044 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.1076 | 0.3029 | 0.3027 |
Echinococcus multilocularis | chromobox protein 1 | 0.0139 | 0.0349 | 0.0349 |
Plasmodium falciparum | DNase I-like protein, putative | 0.0048 | 0.0087 | 0.0223 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0046 | 0.0082 | 0.0079 |
Schistosoma mansoni | xp-G/rad2 DNA repair endonuclease family member | 0.0039 | 0.0062 | 0.006 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.018 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.0207 | 0.0207 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.0139 | 0.0215 |
Schistosoma mansoni | cpg binding protein | 0.0033 | 0.0043 | 0.0042 |
Schistosoma mansoni | rotamase | 0.0137 | 0.0341 | 0.034 |
Brugia malayi | Smad1 | 0.0033 | 0.0045 | 0.0043 |
Entamoeba histolytica | chromodomain-helicase-DNA-binding protein, putative | 0.0023 | 0.0015 | 0.0027 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1339 | 0.3781 | 0.3779 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0237 | 0.0628 | 0.0626 |
Schistosoma mansoni | DNA polymerase eta | 0.0165 | 0.0423 | 0.0421 |
Schistosoma mansoni | tubulin subunit alpha | 0.0471 | 0.1297 | 0.1296 |
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0084 |
Schistosoma mansoni | lamin | 0.0084 | 0.019 | 0.0188 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0292 | 0.0292 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0764 | 0.2137 | 0.6779 |
Schistosoma mansoni | hypothetical protein | 0.0088 | 0.0201 | 0.02 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0746 | 0.2085 | 0.2085 |
Toxoplasma gondii | 'chromo' (CHRromatin Organization MOdifier) domain-containing protein | 0.0023 | 0.0015 | 0.0033 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.004 | 0.0064 | 0.0125 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.012 | 0.0292 | 0.059 |
Trypanosoma brucei | unspecified product | 0.0095 | 0.0222 | 0.022 |
Trypanosoma brucei | epsilon tubulin | 0.0384 | 0.1047 | 0.1045 |
Echinococcus multilocularis | Smad4 | 0.0033 | 0.0045 | 0.0045 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0147 | 0.0369 | 0.0368 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0048 | 0.0087 | 0.0084 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0051 | 0.0094 | 0.1011 |
Plasmodium falciparum | exodeoxyribonuclease III, putative | 0.0048 | 0.0087 | 0.0223 |
Leishmania major | trypanothione reductase | 0.0085 | 0.0194 | 0.0191 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0096 | 0.0225 | 0.0225 |
Giardia lamblia | Gamma tubulin | 0.0384 | 0.1049 | 0.6031 |
Mycobacterium ulcerans | hypothetical protein | 0.012 | 0.0292 | 0.0529 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0077 | 0.0171 | 0.0344 |
Toxoplasma gondii | tubulin/FtsZ family, GTPase domain-containing protein | 0.0351 | 0.0955 | 0.2522 |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0223 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0021 | 0.0021 |
Plasmodium falciparum | tubulin epsilon chain, putative | 0.0384 | 0.1047 | 0.2765 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.019 | 0.0493 | 0.0492 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0065 | 0.0136 | 0.0134 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0147 | 0.0369 | 0.0971 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0193 | 0.0501 | 0.1015 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.0062 | 0.0059 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.003 | 0.0034 | 0.0032 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0066 | 0.0139 | 0.0361 |
Trypanosoma cruzi | DNA repair protein RAD2, putative | 0.0039 | 0.0062 | 0.0059 |
Schistosoma mansoni | chromobox protein | 0.0139 | 0.0349 | 0.0347 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.1196 | 0.3372 | 0.337 |
Mycobacterium ulcerans | transmembrane carbonic anhydrase, SulP | 0.0037 | 0.0056 | 0.0045 |
Echinococcus granulosus | carbonic anhydrase | 0.1339 | 0.3781 | 0.3781 |
Brugia malayi | isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0105 |
Trichomonas vaginalis | Phospholipase C precursor, putative | 0.0048 | 0.0087 | 0.0172 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0048 | 0.0087 | 0.0172 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0165 | 0.0423 | 0.0421 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase, putative | 0.0042 | 0.0069 | 0.0066 |
Mycobacterium tuberculosis | Conserved protein | 0.012 | 0.0292 | 0.0831 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0087 | 0.0087 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0324 | 0.0876 | 0.0876 |
Loa Loa (eye worm) | helicase | 0.0023 | 0.0015 | 0.0015 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0042 | 0.0069 | 0.0177 |
Echinococcus granulosus | peroxisome assembly protein 26 | 0.0471 | 0.1297 | 0.1297 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0304 | 0.0819 | 0.0819 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1297 | 0.2637 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0003 | 0.0003 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.031 | 0.0836 | 0.1698 |
Brugia malayi | Probable ClpP-like protease | 0.0147 | 0.0369 | 0.0367 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Giardia lamblia | hypothetical protein | 0.0039 | 0.0062 | 0.0341 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.012 | 0.0292 | 0.0831 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.004 | 0.0064 | 0.05 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0088 | 0.0202 | 0.02 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0193 | 0.0501 | 0.0501 |
Loa Loa (eye worm) | alpha-tubulin | 0.0471 | 0.1297 | 0.1297 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.013 | 0.0321 | 0.0318 |
Plasmodium vivax | importin-beta 2, putative | 0.0025 | 0.0021 | 0.0109 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0216 | 0.0568 | 0.1722 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Loa Loa (eye worm) | tubulin alpha-3 chain | 0.0281 | 0.0752 | 0.0752 |
Echinococcus multilocularis | aryl hydrocarbon receptor | 0.0141 | 0.0355 | 0.0355 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.003 | 0.0035 | 0.0066 |
Echinococcus granulosus | DNA repair protein complementing XP G cells | 0.0039 | 0.0062 | 0.0062 |
Echinococcus multilocularis | Tubulin alpha 1 chain | 0.0471 | 0.1297 | 0.1297 |
Brugia malayi | MH1 domain containing protein | 0.0033 | 0.0045 | 0.0043 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.0086 | 0.0171 |
Schistosoma mansoni | ran | 0.0018 | 0.0002 | 0.0001 |
Plasmodium falciparum | endonuclease/exonuclease/phosphatase family protein, putative | 0.0048 | 0.0087 | 0.0223 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0138 | 0.0344 | 0.0344 |
Trypanosoma brucei | epsilon tubulin | 0.0384 | 0.1047 | 0.1045 |
Echinococcus granulosus | tubulin alpha 1C chain | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0625 | 0.1737 | 0.3534 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.007 | 0.0151 | 0.0148 |
Echinococcus multilocularis | exonuclease 1 | 0.0039 | 0.0062 | 0.0062 |
Echinococcus multilocularis | expressed conserved protein | 0.02 | 0.0521 | 0.0521 |
Schistosoma mansoni | chromobox protein | 0.0139 | 0.0349 | 0.0347 |
Schistosoma mansoni | synaptojanin | 0.0048 | 0.0087 | 0.0085 |
Brugia malayi | CHD4 protein | 0.0025 | 0.002 | 0.0018 |
Trichomonas vaginalis | chromobox protein, putative | 0.0139 | 0.0349 | 0.0705 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1737 | 0.1736 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.003 | 0.0034 | 0.0032 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0092 | 0.0092 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.1037 | 0.2916 | 0.9291 |
Schistosoma mansoni | hypothetical protein | 0.0268 | 0.0715 | 0.0714 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.003 | 0.0034 | 0.0032 |
Echinococcus granulosus | beta tubulin | 0.0625 | 0.1737 | 0.1737 |
Trypanosoma brucei | RNA editing exonuclease 2 | 0.0048 | 0.0087 | 0.0084 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0384 | 0.1049 | 0.2131 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0292 | 0.0292 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0278 |
Onchocerca volvulus | 0.012 | 0.0292 | 0.0805 | |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1339 | 0.3781 | 0.3779 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0268 | 0.0715 | 0.0715 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0194 | 0.0506 | 0.0979 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.003 | 0.0034 | 0.0032 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0078 | 0.0173 | 0.0348 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0237 | 0.0628 | 0.0626 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0277 | 0.0742 | 0.1452 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Brugia malayi | SET domain containing protein | 0.0025 | 0.002 | 0.0018 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0035 | 0.0049 | 0.0048 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0147 | 0.0369 | 0.0971 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0033 | 0.0045 | 0.0045 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0048 | 0.0087 | 0.0087 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.0173 | 0.0173 |
Brugia malayi | hypothetical protein | 0.019 | 0.0494 | 0.0491 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0171 | 0.044 | 0.1309 |
Entamoeba histolytica | tubulin alpha chain, putative | 0.0471 | 0.1297 | 0.2761 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0292 | 0.0292 |
Loa Loa (eye worm) | TAR-binding protein | 0.0054 | 0.0105 | 0.0105 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Schistosoma mansoni | inositol monophosphatase | 0.004 | 0.0064 | 0.0062 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0193 | 0.0501 | 0.1319 |
Trypanosoma brucei | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0048 | 0.0087 | 0.0084 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0212 | 0.0558 | 0.1184 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.006 | 0.0121 | 0.0314 |
Echinococcus multilocularis | neutral sphingomyelinase | 0.0048 | 0.0087 | 0.0087 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0015 | 0.0015 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1297 | 0.1297 |
Onchocerca volvulus | 0.012 | 0.0292 | 0.0805 | |
Brugia malayi | Fli-1 protein | 0.0237 | 0.0627 | 0.0625 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0384 | 0.1047 | 0.2129 |
Brugia malayi | Tubulin beta chain | 0.019 | 0.0494 | 0.0492 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0092 | 0.0091 |
Plasmodium falciparum | flap endonuclease 1 | 0.0193 | 0.0501 | 0.1319 |
Schistosoma mansoni | tubulin subunit gamma | 0.0384 | 0.1049 | 0.1047 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0084 | 0.019 | 0.019 |
Echinococcus multilocularis | DNA repair protein complementing XP G cells | 0.0039 | 0.0062 | 0.0062 |
Trichomonas vaginalis | skeletal muscle/kidney enriched inositol 5-phosphatase, putative | 0.0048 | 0.0087 | 0.0172 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0092 | 0.0092 |
Echinococcus granulosus | tubulin gamma 1 chain | 0.0384 | 0.1049 | 0.1049 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.018 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0039 | 0.0062 | 0.0121 |
Trypanosoma brucei | inositol/phosphatidylinositol phosphatase, putative | 0.0048 | 0.0087 | 0.0084 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0138 | 0.0344 | 0.0343 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.027 | 0.0722 | 0.2219 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.0304 | 0.0304 |
Giardia lamblia | Epsilon tubulin | 0.0193 | 0.0503 | 0.2884 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0062 | 0.0062 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0019 | 0.0003 | 0.0001 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.0086 | 0.017 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | 0.0048 | 0.0087 | 0.0223 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0025 | 0.0021 | 0.0019 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.004 | 0.0064 | 0.0062 |
Brugia malayi | chromobox protein homolog 3 | 0.0078 | 0.0173 | 0.0171 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0237 | 0.0628 | 0.1275 |
Loa Loa (eye worm) | hypothetical protein | 0.0281 | 0.0752 | 0.0752 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1297 | 0.2637 |
Leishmania major | epsilon tubulin, putative | 0.0384 | 0.1047 | 0.1045 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.2546 | 0.7235 | 0.7235 |
Leishmania major | inositol/phosphatidylinositol phosphatase, putative | 0.0048 | 0.0087 | 0.0084 |
Plasmodium falciparum | tubulin delta chain, putative | 0.0161 | 0.0411 | 0.1081 |
Echinococcus multilocularis | carbonic anhydrase | 0.1339 | 0.3781 | 0.3781 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.007 | 0.0151 | 0.0302 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.046 | 0.1267 | 0.1267 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0053 | 0.0101 | 0.02 |
Schistosoma mansoni | hypothetical protein | 0.0441 | 0.121 | 0.1209 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Loa Loa (eye worm) | hypothetical protein | 0.0132 | 0.0327 | 0.0327 |
Plasmodium vivax | DNA repair protein RAD2, putative | 0.0039 | 0.0062 | 0.0341 |
Schistosoma mansoni | hypothetical protein | 0.1339 | 0.3781 | 0.378 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0045 | 0.0078 | 0.0078 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.004 | 0.0064 | 0.0163 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0061 | 0.0061 |
Schistosoma mansoni | tar DNA-binding protein | 0.0054 | 0.0105 | 0.0103 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0055 | 0.0108 | 0.0606 |
Plasmodium falciparum | exonuclease I, putative | 0.0039 | 0.0062 | 0.0157 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0035 | 0.0049 | 0.0049 |
Loa Loa (eye worm) | hypothetical protein | 0.2693 | 0.7655 | 0.7655 |
Echinococcus granulosus | muscleblind protein | 0.0324 | 0.0876 | 0.0876 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0035 | 0.0049 | 0.0048 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1734 | 0.4911 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0055 | 0.0108 | 0.0108 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1734 | 0.4911 | 1 |
Schistosoma mansoni | DNA polymerase IV / kappa | 0.0043 | 0.0072 | 0.0071 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.003 | 0.0034 | 0.0032 |
Schistosoma mansoni | hypothetical protein | 0.0916 | 0.257 | 0.2569 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.012 | 0.0292 | 0.0831 |
Echinococcus multilocularis | synaptojanin 1 | 0.0048 | 0.0087 | 0.0087 |
Entamoeba histolytica | endonuclease/exonuclease/phosphatase domain containing protein | 0.0048 | 0.0087 | 0.018 |
Wolbachia endosymbiont of Brugia malayi | cell division protein FtsZ | 0.0161 | 0.0411 | 0.6337 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Trichomonas vaginalis | sphingomyelinase C 2 precursor, putative | 0.0048 | 0.0087 | 0.0172 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0065 | 0.0065 |
Brugia malayi | Inositol-1 | 0.004 | 0.0064 | 0.0062 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.012 | 0.0292 | 0.0831 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Trichomonas vaginalis | mercuric reductase, putative | 0.003 | 0.0034 | 0.0065 |
Echinococcus granulosus | tubulin beta 4A class IVa | 0.0625 | 0.1737 | 0.1737 |
Plasmodium vivax | endonuclease/exonuclease/phosphatase domain containing protein | 0.0048 | 0.0087 | 0.0486 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1297 | 0.1295 |
Brugia malayi | Valyl-tRNA synthetase | 0.0023 | 0.0015 | 0.0013 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0015 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0015 | 0.0015 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0063 | 0.0131 | 0.0131 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.003 | 0.0034 | 0.0033 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.0034 | 0.0065 |
Loa Loa (eye worm) | hypothetical protein | 0.1196 | 0.3372 | 0.3372 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.003 | 0.0034 | 0.0032 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.002 | 0.0008 | 0.0011 |
Brugia malayi | bHLH-PAS transcription factor | 0.0048 | 0.0088 | 0.0086 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0085 | 0.0194 | 0.0514 |
Schistosoma mansoni | neutral sphingomyelinase | 0.0048 | 0.0087 | 0.0085 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0065 | 0.0136 | 0.0136 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0193 | 0.0501 | 0.0498 |
Brugia malayi | MH2 domain containing protein | 0.0033 | 0.0045 | 0.0043 |
Mycobacterium ulcerans | transferase | 0.0077 | 0.0171 | 0.0281 |
Leishmania major | peptidyl-prolyl cis-trans isomerase, putative | 0.0042 | 0.0069 | 0.0066 |
Echinococcus granulosus | carbonic anhydrase II | 0.3512 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.007 | 0.0151 | 0.0302 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0165 | 0.0423 | 0.0421 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0046 | 0.008 | 0.008 |
Plasmodium falciparum | alpha tubulin 2 | 0.0471 | 0.1297 | 0.3426 |
Leishmania major | RNA-editing complex protein MP100, putative | 0.0048 | 0.0087 | 0.0084 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0019 | 0.0003 | 0.0003 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1297 | 0.2637 |
Loa Loa (eye worm) | endonuclease/Exonuclease/phosphatase | 0.0048 | 0.0087 | 0.0087 |
Mycobacterium tuberculosis | Probable DNA polymerase IV DinX (pol IV 1) (DNA nucleotidyltransferase (DNA-directed)) | 0.0035 | 0.0048 | 0.0046 |
Schistosoma mansoni | hypothetical protein | 0.034 | 0.0924 | 0.0923 |
Echinococcus granulosus | importin subunit beta 1 | 0.0025 | 0.0021 | 0.0021 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0048 | 0.0088 | 0.0088 |
Trichomonas vaginalis | set domain proteins, putative | 0.0272 | 0.0727 | 0.1477 |
Trypanosoma brucei | exonuclease, putative | 0.0039 | 0.0062 | 0.0059 |
Schistosoma mansoni | chromobox protein | 0.0023 | 0.0015 | 0.0013 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0193 | 0.0501 | 0.2872 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0055 | 0.0108 | 0.0105 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0502 | 0.1386 | 0.1386 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0046 | 0.008 | 0.0079 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0039 | 0.0062 | 0.0157 |
Echinococcus granulosus | tubulin alpha 3 chain | 0.0471 | 0.1297 | 0.1297 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0048 | 0.0087 | 0.0172 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0154 | 0.039 | 0.0388 |
Leishmania major | hypothetical protein, conserved | 0.0048 | 0.0087 | 0.0084 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0088 | 0.0202 | 0.02 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0147 | 0.0369 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.007 | 0.0151 | 0.0149 |
Loa Loa (eye worm) | tubulin alpha 2 | 0.0119 | 0.0291 | 0.0291 |
Loa Loa (eye worm) | glutathione reductase | 0.0085 | 0.0194 | 0.0194 |
Schistosoma mansoni | tubulin subunit epsilon | 0.0384 | 0.1047 | 0.1046 |
Echinococcus granulosus | chromodomain helicase DNA binding protein 1 | 0.0023 | 0.0015 | 0.0015 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.0086 | 0.017 |
Brugia malayi | XPG I-region family protein | 0.0039 | 0.0062 | 0.0059 |
Schistosoma mansoni | ap endonuclease | 0.0237 | 0.0628 | 0.0627 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0042 | 0.0069 | 0.0067 |
Loa Loa (eye worm) | tubulin beta chain | 0.0161 | 0.0411 | 0.0411 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0154 | 0.039 | 0.0388 |
Trypanosoma brucei | trypanothione reductase | 0.0085 | 0.0194 | 0.0191 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.003 | 0.0034 | 0.0033 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0046 | 0.008 | 0.008 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0277 | 0.0742 | 0.074 |
Loa Loa (eye worm) | Pin1-type peptidyl-prolyl cis-trans isomerase | 0.0137 | 0.0341 | 0.0341 |
Onchocerca volvulus | 0.0061 | 0.0125 | 0.032 | |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0046 | 0.008 | 0.0079 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0023 | 0.0015 | 0.0033 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0046 | 0.008 | 0.0159 |
Echinococcus granulosus | chromobox protein 2 | 0.0023 | 0.0015 | 0.0015 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1737 | 0.1737 |
Schistosoma mansoni | tubulin subunit alpha | 0.0161 | 0.0411 | 0.0409 |
Plasmodium falciparum | tubulin beta chain | 0.0625 | 0.1737 | 0.4591 |
Leishmania major | beta tubulin | 0.0625 | 0.1737 | 0.1735 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.034 | 0.0924 | 0.0924 |
Echinococcus granulosus | Jumonji AT rich interactive domain 1B | 0.0019 | 0.0003 | 0.0003 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Targets |
---|---|---|---|---|---|---|
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26882 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26953 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25756 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29777 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25113 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29099 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28601 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24472 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21739 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28044 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21309 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24440 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22594 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23453 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21545 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29554 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29031 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23905 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21179 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25450 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22205 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 27459 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26961 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22252 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23996 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23078 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20827 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28024 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28324 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26882 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26953 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25756 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29777 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25113 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29099 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28601 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24472 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21739 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28044 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21309 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24440 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22594 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23453 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21545 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29554 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29031 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23905 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21179 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25450 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22205 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 27459 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26961 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22252 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23996 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23078 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20827 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28024 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28324 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 26882 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 26953 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29919 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 25756 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29777 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 25113 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29099 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28601 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 24472 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21739 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28044 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21309 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 24440 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 20919 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 22594 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23453 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21545 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29554 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29031 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23905 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21179 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 25450 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 22205 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 27459 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 26961 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 22252 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23996 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23078 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 20827 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28024 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28324 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 |
7 literature references were collected for this gene.